Publications
Print PDF
Gilead Abandons Orphan Drug Designation for COVID-19 Drug
March 25, 2020
Mari Serebrov
BioWorld

Axinn partner Chad Landmon was quoted in the BioWorld article, "Gilead Abandons Orphan Drug Designation for COVID-19 Drug."

Click here to access the article.

By using the Axinn, Veltrop & Harkrider LLP website with cookies enabled on your browser, you agree to our use of cookies during your browsing experience. Learn more about our privacy policy.